TABLE 5.

Logistic Regression Model for Predictors of VLS in All CALHIV Using an SDS With DTG

Characteristic	OR (95% CI)
Female	0.87 (0.60–1.28)
Average age in years	0.90 (0.84–0.96)
Average time on ART before DTG in years	0.99 (0.94–1.04)
Virally suppressed before DTG	3.16 (1.68–5.94)
Any malnutrition	0.70 (0.27–1.82)
History of TB disease	Indet.*
Using single tab TLD regimen	2.02 (1.27–3.19)

^*Indeterminant due to small sample size and/or outcome event rate not allowing for enough power to report an OR.

ART indicates antiretroviral therapy; CALHIV, children and adolescents living with HIV; CI, confidence interval; DTG, dolutegravir; OR, odds ratio; SDS, single drug substitution; TB, tuberculosis; TLD, tenofovir-lamivudine-dolutegravir fixed drug combination.